Integrated Filing — IndAS



General information about company

Scrip Code 544292
NSE Symbol ONESOURCE
MSEI Symbol NOTLISTED
ISIN INE013P01021
Name of company ONESOURCE SPECIALTY PHARMA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharma
Start date and time of board meeting 13-05-2026   11:30:00
End date and time of board meeting 13-05-2026   12:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 10-12-2024
Indicate Company website link for updated RPT policy of the Company https://www.onesourcecdmo.com/investor-relations/disclosures-under-regulation-46-lodr/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable for the for the period under review



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 41,896.20 1,40,538.10
Other income 209.30 1,500.80
Total income 42,105.50 1,42,038.90
2 Expenses
(a) Cost of materials consumed 14,543.20 44,126.10
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 175.50 327.40
(d) Employee benefit expense 6,164.90 24,044.70
(e) Finance costs 2,225.20 12,057.60
(f) Depreciation, depletion and amortisation expense 3,473.80 13,679.50
(f) Other Expenses
1 Power & Fuel 943.20 3,553.30
2 Rates and taxes 636.70 1,897.50
3 Rent 194.00 1,099.90
4 Insurance 73.90 879.90
5 Repair and maintance - Machinery 857.70 2,800.70
6 Repair and maintance - Others 1,367.10 6,037.80
7 Housekeeping service 269.30 1,159.40
8 Legal and professional fees 4,874.60 15,465.80
9 Support service charges 1,851.20 6,097.80
10 Miscellaneous expenses 2,474.30 6,148.50
Total other expenses 13,542.00 45,140.60
Total expenses 40,124.60 1,39,375.90
3 Total profit before exceptional items and tax 1,980.90 2,663.00
4 Exceptional items 167.00 (542.00)
5 Total profit before tax 2,147.90 2,121.00
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax 0.00 0.00
9 Total tax expenses 0.00 0.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,147.90 2,121.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,147.90 2,121.00
17 Other comprehensive income net of taxes 0.60 45.70
18 Total Comprehensive Income for the period 2,148.50 2,166.70
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,146.20 1,146.20
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 5,93,876.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.87 1.85
Diluted earnings (loss) per share from continuing operations 1.87 1.85
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.87 1.85
Diluted earnings (loss) per share from continuing and discontinued operations 1.87 1.85
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 92,585.70
Capital work-in-progress 31,389.60
Investment property 0.00
Goodwill 1,97,614.20
Other intangible assets 29,558.40
Intangible assets under development 15,467.80
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 2,92,571.50
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 22,715.80
Total of other non-current financial assets 22,715.80
Total non-current financial assets 3,15,287.30
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 0.00
Total of other non-current assets 0.00
Total non-current assets 6,81,903.00
2 Current assets
Inventories 43,895.80
Current financial asset
Current investments 545.90
Trade receivables, current 73,524.50
Cash and cash equivalents 2,805.90
Bank balance other than cash and cash equivalents 6,189.20
Loans, current 0.00
Other current financial assets
Total of other current financial assets 1,645.90
Total current financial assets 84,711.40
Current tax assets (net)
Other current assets
1 Other current assets 17,095.70
Total of other current assets 17,095.70
Total current assets 1,45,702.90
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 8,27,605.90
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,146.20
Other equity 5,93,876.00
Total equity attributable to owners of parent 5,95,022.20
Non controlling interest
Total equity 5,95,022.20
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 56,370.30
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 21,892.50
Total of other non-current financial liabilities 21,892.50
Total non-current financial liabilities 78,262.80
Provisions, non-current 1,825.20
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 102.60
Total of other non-current liabilities 102.60
Total non-current liabilities 80,190.60
Current liabilities
Current financial liabilities
Borrowings, current 71,259.30
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,196.60
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 37,997.30
Total Trade payable 40,193.90
Other current financial liabilities
1 Other current financial liabilities 13,206.70
Total of other current financial liabilities 13,206.70
Total current financial liabilities 1,24,659.90
Other current liabilities 27,733.20
1 Other current liabilities 25,968.40
2 Provisions, current 1,276.80
3 Current tax liabilities (Net) 0.00
4 Deferred government grants, Current 488.00
Total of other current liabilities 27,733.20
Provisions, current 0.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1,52,393.10
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,32,583.70
Total equity and liabilites 8,27,605.90
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of post employment benefit obligations- gain/(loss) 0.60 45.70
Total Amount of items that will not be reclassified to profit and loss 0.60 45.70
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 0.60 45.70



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,121.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 12,057.60
Adjustments for decrease (increase) in inventories (28,552.30)
Adjustments for decrease (increase) in trade receivables, current (21,328.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 957.40
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 23,815.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 4,252.70
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 13,679.50
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (1,696.80)
Adjustments for dividend income 0.00
Adjustments for interest income 1,168.00
Adjustments for share-based payments 271.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (12.30)
Other adjustments for non-cash items 790.10
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 3,065.90
Net cash flows from (used in) operations 5,186.90
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) (330.60)
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 5,517.50
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 8,543.20
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1.00
Purchase of property, plant and equipment 47,597.40
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received (0.30)
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 8,379.90
Net cash flows from (used in) investing activities (47,760.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 574.40
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 70,380.70
Repayments of borrowings 20,739.40
Payments of lease liabilities 2,360.60
Dividends paid 0.00
Interest paid 11,749.20
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 36,105.90
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (6,136.60)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (6,136.60)
Cash and cash equivalents cash flow statement at beginning of period 9,208.60
Cash and cash equivalents cash flow statement at end of period 3,072.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells Yes 30-04-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 OneSource Specialty Pharma Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Support Service charges 4,000.00 NA 3,655.60 0.00 0.00
2 OneSource Specialty Pharma Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Reimbursement of expenses 500.00 NA 372.30 0.00 0.00
3 OneSource Specialty Pharma Limited Biolexis Private Limited Subsidiary Any other transaction Reimbursement of expenses 500.00 NA 25.50 0.00 0.00
4 OneSource Specialty Pharma Limited Biolexis Pte Limited Step down Subsidiary Any other transaction Reimbursement of expenses 500.00 NA 552.90 0.00 0.00
5 OneSource Specialty Pharma Limited Chayadeep Properties Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Rental Expenses 585.00 NA 210.00 04-08-2025 442.70 0.00 0.00
6 OneSource Specialty Pharma Limited Fairmed Healthcare GmbH Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 311.70 0.00 0.00
7 OneSource Specialty Pharma Limited Karuna Business Solutions LLP Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Rental Expenses 1,320.00 NA 1,058.20 0.00 0.00
8 OneSource Specialty Pharma Limited OneSource Softgels Pte. Ltd Subsidiary Any other transaction Reimbursement of expenses 500.00 NA 47.60 0.00 0.00
9 OneSource Specialty Pharma Limited OneSource Softgels Pte. Ltd Subsidiary Any other transaction Royalty expenses 3,285.00 NA 1,528.00 0.00 0.00
10 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Reimbursement of expenses 500.00 NA 655.20 0.00 0.00
11 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Royalty expenses 2,025.00 NA 771.00 0.00 0.00
12 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Sale of goods or services 17,100.00 NA 7,536.50 0.00 0.00
13 OneSource Specialty Pharma Limited Six Rays Pte. Limited Person or entity forming a part of the promoter or promoter group of the listed entity Sale of goods or services 0.00 NA 3,000.00 04-08-2025 1,067.80 0.00 0.00
14 OneSource Specialty Pharma Limited Solara Active Pharma Sciences Limited Public Companies - Common Director Purchase of goods or services 1,000.00 NA 470.80 0.00 0.00
15 OneSource Specialty Pharma Limited Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Sale of goods or services 2,000.00 NA 1,500.00 04-08-2025 3,463.30 0.00 0.00
16 OneSource Specialty Pharma Limited Steriscience Sp.Zoo, Poland Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Reimbursement of expenses 500.00 NA 113.80 0.00 0.00
17 OneSource Specialty Pharma Limited Steriscience Specialties Private Limited Private Companies - Promoter Group Any other transaction Interest expense on Loan 700.00 NA 359.00 0.00 0.00
18 OneSource Specialty Pharma Limited Steriscience Specialties Private Limited Private Companies - Promoter Group Any other transaction Reimbursement of expenses 500.00 NA 153.80 0.00 0.00
19 OneSource Specialty Pharma Limited Strides Pharma (Cyprus) Limited Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 276.20 0.00 0.00
20 OneSource Specialty Pharma Limited Strides Pharma (Cyprus) Limited Entity and the reporting entity are members of the same group Sale of goods or services 2,000.00 NA 837.40 0.00 0.00
21 OneSource Specialty Pharma Limited Strides Pharma Canada Inc. Entity and the reporting entity are members of the same group Sale of goods or services 750.00 NA 250.00 04-08-2025 296.30 0.00 0.00
22 OneSource Specialty Pharma Limited Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Sale of goods or services 0.00 NA 1,700.00 04-08-2025 827.70 0.00 0.00
23 OneSource Specialty Pharma Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Sale of goods or services 50,000.00 NA 26,420.90 0.00 0.00
24 OneSource Specialty Pharma Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 500.00 04-08-2025 929.50 0.00 0.00
25 OneSource Specialty Pharma Limited Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 1,000.00 04-08-2025 588.40 0.00 0.00
26 OneSource Specialty Pharma Limited Strides Pharma International AG Entity and the reporting entity are members of the same group Sale of goods or services 2,500.00 NA 1,000.00 04-08-2025 1,752.80 0.00 0.00
27 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Sale of goods or services 500.00 NA 6,500.00 04-08-2025 1,579.80 0.00 0.00
28 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Purchase of goods or services 13,000.00 NA 11,260.90 0.00 0.00
29 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Reimbursement of expenses 1,000.00 NA 965.30 0.00 0.00
30 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Rental Expenses 10.00 NA 3.70 0.00 0.00
31 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Sale of goods or services 900.00 NA 16,100.00 04-08-2025 4,674.60 0.00 0.00
32 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Capital Expenditure 0.00 NA 1,000.00 04-08-2025 21.70 0.00 0.00
33 OneSource Specialty Pharma Limited Strides Pharma Science Pty Ltd Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 3.90 0.00 0.00
34 OneSource Specialty Pharma Limited Strides Pharma UK Limited Entity and the reporting entity are members of the same group Sale of goods or services 4,000.00 NA 848.40 0.00 0.00
35 OneSource Specialty Pharma Limited Strides Pharma UK Limited Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 500.00 NA 31.30 0.00 0.00
36 OneSource Specialty Pharma Limited Strides South Africa Pty Ltd Entity and the reporting entity are members of the same group Sale of goods or services 1,500.00 NA 1,500.00 04-08-2025 355.80 0.00 0.00
37 OneSource Specialty Pharma Limited Instapill Private Limited (Formally known as Tenshi kaizan Private limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Reimbursement of expenses 500.00 NA 265.00 0.00 0.00
38 OneSource Specialty Pharma Limited Instapill Private Limited (Formally known as Tenshi kaizan Private limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Support Service charges 1,000.00 NA 2,466.80 0.00 0.00
39 OneSource Specialty Pharma Limited Instapill Private Limited (Formally known as Tenshi kaizan Private limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Capital Expenditure 0.00 NA 400.00 04-08-2025 265.00 0.00 0.00
40 OneSource Specialty Pharma Limited Instapill Private Limited (Formally known as Tenshi kaizan Private limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Suport Service Income 0.00 NA 500.00 04-08-2025 176.30 0.00 0.00
41 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Guarantee Commission 100.00 NA 6.80 0.00 0.00
42 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Reimbursement of expenses 500.00 NA 500.00 04-08-2025 65.10 0.00 0.00
43 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Suport Service Income 250.00 NA 750.00 04-08-2025 48.20 0.00 0.00
44 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Support Service charges 1,000.00 NA 379.10 0.00 0.00
45 OneSource Specialty Pte Ltd Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Purchase of IP 6,000.00 NA 6,000.00 0.00 0.00
46 OneSource Specialty Pte Ltd Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Reimbursement of expenses 0.00 NA 500.00 04-08-2025 150.50 0.00 0.00
47 OneSource Specialty Pte Ltd Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Support Service charges 50.00 NA 450.00 04-08-2025 30.30 0.00 0.00
48 OneSource Specialty Pte Ltd Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Revenue from Operations 6,000.00 NA 10,000.00 04-08-2025 1,021.90 0.00 0.00
49 OneSource Specialty Pte Ltd Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 0.00 NA 500.00 04-08-2025 1.10 0.00 0.00
50 OneSource Specialty Pte Ltd Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Revenue from Operations 0.00 NA 500.00 04-08-2025 22.50 0.00 0.00
51 OneSource Specialty Pte Ltd Strides Pharma UK Limited Entity and the reporting entity are members of the same group Any other transaction Revenue from Operations 0.00 NA 500.00 04-08-2025 44.90 0.00 0.00
52 OneSource Specialty Pte Ltd Biolexis Pte Limited Subsidiary Any other transaction Interest Income on Loan 40.00 NA 9.40 0.00 0.00
53 Stelis Pte Ltd Biolexis Pte Limited Subsidiary Any other transaction Interest Income on Loan 40.00 NA 26.10 0.00 0.00
54 Strides Pharma Services Private Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Rental Expenses 10.00 NA 0.50 0.00 0.00
55 OneSource Specialty Pharma Limited Six Rays Pte. Limited Person or entity forming a part of the promoter or promoter group of the listed entity Advance 0.00 NA 0.00 0.00 41.50
56 OneSource Specialty Pharma Limited Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Advance 0.00 NA 0.00 891.80 382.60
57 OneSource Specialty Pharma Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 215.50 738.50
58 OneSource Specialty Pharma Limited Fairmed Healthcare GmbH Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 0.00 161.50
59 OneSource Specialty Pharma Limited Instapill Private Limited (fomally known as Tenshi Kaizen Private Limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 0.00 175.20
60 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 8,763.80
61 OneSource Specialty Pharma Limited Solara Active Pharma Sciences Limited Public Companies - Common Director Any other transaction Trade Payable 0.00 NA 0.00 59.30 277.40
62 OneSource Specialty Pharma Limited Stelis Pte. Ltd Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 0.00
63 OneSource Specialty Pharma Limited Steriscience Specialties Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 0.00 179.90
64 OneSource Specialty Pharma Limited Strides Pharma (Cyprus) Limited Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 0.00 15.80
65 OneSource Specialty Pharma Limited Strides Pharma Inc Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 0.00 214.70
66 OneSource Specialty Pharma Limited Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 0.00 89.70
67 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Trade Payable 0.00 NA 0.00 224.50 2,727.00
68 OneSource Specialty Pharma Limited Strides Pharma UK Limited Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 0.00 17.30
69 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 20.80 7.90
70 OneSource Specialty Pharma Limited Biolexis Private Limited Subsidiary Any other transaction Other Receivable 0.00 NA 0.00 0.00 406.40
71 OneSource Specialty Pharma Limited Chayadeep Properties Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Security deposit paid 0.00 NA 0.00 193.00 234.80
72 OneSource Specialty Pharma Limited Biolexis Private Limited Subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 36.90
73 OneSource Specialty Pharma Limited Biolexis Pte Limited Step down Subsidiary Any other transaction Trade Payable 0.00 NA 0.00 3.90 36.40
74 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Investment 0.00 NA 0.00 1,49,115.70 1,70,621.30
75 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 7,471.50 6,927.80
76 OneSource Specialty Pharma Limited Six Rays Pte. Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Receivable 0.00 NA 0.00 0.00 406.90
77 OneSource Specialty Pharma Limited Stelis Pte. Ltd Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 5,623.90 0.00
78 OneSource Specialty Pharma Limited Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Receivable 0.00 NA 0.00 4,927.90 2,135.90
79 OneSource Specialty Pharma Limited Strides Pharma (Cyprus) Limited Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 86.50 567.30
80 OneSource Specialty Pharma Limited Strides South Africa Pty Ltd Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 377.80
81 OneSource Specialty Pharma Limited Strides Pharma Canada Inc. Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 145.80 303.70
82 OneSource Specialty Pharma Limited Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 570.90
83 OneSource Specialty Pharma Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 4,339.30
84 OneSource Specialty Pharma Limited Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 563.10 1,365.10
85 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Trade Receivable 0.00 NA 0.00 1.50 4,570.70
86 OneSource Specialty Pharma Limited Strides Pharma Services Private Limited Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 0.00 6.10
87 OneSource Specialty Pharma Limited Strides Pharma UK Limited Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 951.80 617.30
88 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Other Payables 0.00 NA 0.00 0.00 5,661.20
89 OneSource Specialty Pharma Limited OneSource Specialty Pte Ltd Subsidiary Any other transaction Interest receivable 0.00 NA 0.00 0.00 830.60
90 OneSource Specialty Pharma Limited Biolexis Private Limited Subsidiary Investment 0.00 NA 0.00 3,875.10 3,875.10
91 OneSource Specialty Pharma Limited Biolexis Private Limited Subsidiary Investment 0.00 NA 0.00 (3,863.30) (3,863.30)
92 OneSource Specialty Pharma Limited Karuna Business Solutions LLP Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 47.70 47.20
93 OneSource Specialty Pharma Limited Brooks Steriscience Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Receivable 0.00 NA 0.00 723.90 0.00
94 OneSource Specialty Pharma Limited OneSource Softgels Pte. Ltd Subsidiary Any other transaction Trade Receivable 0.00 NA 0.00 9,762.20 0.00
95 OneSource Specialty Pharma Limited Steriscience Sp.Zoo, Poland Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 1,088.20 0.00
96 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Receivable 0.00 NA 0.00 85.60 0.00
97 OneSource Specialty Pharma Limited Chayadeep Properties Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Advance 0.00 NA 0.00 1.00 0.00
98 OneSource Specialty Pharma Limited Instapill Private Limited (fomally known as Tenshi Kaizen Private Limited) Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade payable 0.00 NA 0.00 0.00 0.00
99 OneSource Specialty Pharma Limited Instapill Private Limited (fomally known as Tenshi Kaizen Private Limited) Person or entity forming a part of the promoter or promoter group of the listed entity Advance 0.00 NA 0.00 66.20 0.00
100 OneSource Specialty Pharma Limited Strides Pharma Services Private Limited Subsidiary Investment 0.00 NA 0.00 1,21,136.80 1,21,136.80
101 Biolexis Private Limited Biolexis Pte Limited Subsidiary Investment 0.00 NA 0.00 5,169.90 5,169.90
102 Biolexis Private Limited Biolexis Pte Limited Subsidiary Investment 0.00 NA 0.00 488.70 488.70
103 Biolexis Private Limited Biolexis Pte Limited Subsidiary Any other transaction Provision for Impairment 0.00 NA 0.00 (5,654.50) 0.00
104 Stelis Pte Ltd Biolexis Pte Limited Step down Subsidiary Any other transaction Interest receivable 0.00 NA 0.00 20.10 0.00
105 Stelis Pte Ltd OneSource Specialty Pte Ltd Subsidiary Any other transaction Interest receivable 0.00 NA 0.00 13.70 0.00
106 OneSource Specialty Pte Ltd Steriscience Pte Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Other Payables 0.00 NA 0.00 1,033.00 0.00
107 OneSource Specialty Pharma Limited Steriscience Specialties Private Limited Private Companies - Promoter Group Loan 0.00 NA 4,557.30 4,557.30 0.00 Inter-corporate deposit 12.200 5 years Secured NA Textual Information(1)
108 Stelis Pte Ltd Biolexis Pte Limited Step down Subsidiary Loan 0.00 NA 0.00 1,097.90 0.00 Loan 3.00 1 year Unsecured NA Textual Information(2)
109 Stelis Pte Ltd OneSource Specialty Pte Ltd Subsidiary Loan 0.00 NA 0.00 6,407.60 0.00 Loan 6.500 1 year Unsecured NA Textual Information(3)
110 OneSource Specialty Pharma Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 706.10 0.00
111 OneSource Specialty Pharma Limited Fairmed Healthcare GmbH Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 9.60 0.00
112 OneSource Specialty Pharma Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 56.50 0.00
113 OneSource Specialty Pharma Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Trade Payable 0.00 NA 0.00 930.60 0.00
114 OneSource Specialty Pharma Limited Tenshi Pharmaceuticals Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 23.70 0.00
115 OneSource Specialty Pharma Limited Biolexis Pte Limited Step down Subsidiary Any other transaction Other Receivable 0.00 NA 0.00 60.00 0.00
116 OneSource Specialty Pharma Limited Biolexis Pte Limited Step down Subsidiary Any other transaction Trade Payable 0.00 NA 0.00 (20.70) 0.00
117 OneSource Specialty Pharma Limited Karuna Business Solutions LLP Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Security deposit paid 0.00 NA 0.00 708.20 708.20
118 Strides Pharma Services Private Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 1.40 2.00
119 OneSource Softgels PTE.Limited Strides Nordic Aps Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Receivable 0.00 NA 0.00 172.40 0.00
120 OneSource Softgels PTE.Limited Strides Pharma (Cyprus) Limited Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 85.70 0.00
121 OneSource Softgels PTE.Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 7,827.00 68.50
122 OneSource Softgels PTE.Limited Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 65.10 23.60
123 OneSource Softgels PTE.Limited Strides Pharma Uk Ltd Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 3.80
124 OneSource Softgels PTE.Limited Strides South Africa Pty Ltd Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 165.00 0.00
125 OneSource Specialty Pte Ltd Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 1,301.90 68.50
126 Biolexis PTE. Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 42.20 0.00
127 Biolexis PTE. Limited Six Rays Pte. Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 0.40 0.40
128 OneSource Softgels PTE.Limited Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 309.70 6.80
129 OneSource Softgels PTE.Limited Strides Pharma Science Limited Public Companies - Director is Director Any other transaction Trade Payable 0.00 NA 0.00 9,741.20 0.00
130 OneSource Specialty Pte Ltd Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 214.10 0.00
131 OneSource Specialty Pte Ltd Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 35.90 0.00
132 Stelis Pte Ltd Arcolab Private Limited Private Companies - Promoter Group Any other transaction Trade Payable 0.00 NA 0.00 1.00 0.00
133 OneSource Softgels PTE.Limited Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Advance 0.00 NA 0.00 309.70 0.00
134 OneSource Specialty Pte Ltd Stelis Pte. Ltd Subsidiary Interest received 800.00 NA 26.10 0.00 0.00
135 OneSource Specialty Pharma Limited Chayadeep Properties Private Limited Person or entity forming a part of the promoter or promoter group of the listed entity Any other transaction Trade Payable 0.00 NA 0.00 5.10 13.60
136 OneSource Specialty Pharma Limited Stelis Pte. Ltd Subsidiary Sale of goods or services 4,350.00 NA 421.60 0.00 0.00
137 OneSource Specialty Pharma Limited Stelis Pte. Ltd Subsidiary Any other transaction Reimbursement of expenses 500.00 NA 206.50 0.00 0.00
138 OneSource Specialty Pharma Limited Stelis Pte. Ltd Subsidiary Investment 0.00 NA 3,148.60 0.00 0.00
139 OneSource Specialty Pharma Limited Strides Pharma Services Private Limited Subsidiary Any other transaction Reimbursement of expenses 0.00 NA 0.00 0.00 0.00
140 OneSource Specialty Pharma Limited Serovia Holdings Limited, Cyprus Person or entity forming a part of the promoter or promoter group of the listed entity Sale of goods or services 1,000.00 NA 521.60 0.00 0.00
141 OneSource Specialty Pte Ltd OneSource Softgels Pte. Ltd Step down Subsidiary Any other transaction Interest expense on Loan 0.00 NA 12.80 0.00 0.00
142 OneSource Specialty Pte Ltd OneSource Softgels Pte. Ltd Step down Subsidiary Loan 0.00 NA 391.50 0.00 0.00 Loan 0 5 Loan 6.500 5 years Unsecured NA Textual Information(4)
143 OneSource Specialty Pte Ltd Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 0.00 NA 30.30 0.00 0.00
144 OneSource Softgels PTE.Limited Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Reimbursement of expenses 0.00 NA 35.00 0.00 0.00
145 OneSource Specialty Pharma Limited OneSource Softgels Pte. Ltd Subsidiary Any other transaction Trade Payable 0.00 NA 0.00 0.00 1,559.20
146 OneSource Specialty Pte Ltd Strides Pharma International AG Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 23.60
147 OneSource Specialty Pte Ltd Strides Pharma Uk Ltd Entity and the reporting entity are members of the same group Any other transaction Trade Receivable 0.00 NA 0.00 0.00 3.80
148 OneSource Specialty Pte Ltd Biolexis Pte Limited Step down Subsidiary Loan 0.00 NA 0.00 0.00 1,358.60
149 OneSource Specialty Pte Ltd Strides Pharma Global Pte Limited Entity and the reporting entity are members of the same group Any other transaction Trade Payable 0.00 NA 0.00 0.00 6.80
150 OneSource Specialty Pharma Limited Strides Pharma Inc Entity and the reporting entity are members of the same group Any other transaction Support Service charges 0.00 NA 1,000.00 04-08-2025 147.10 0.00 0.00
151 OneSource Specialty Pharma Limited Instapill Private Limited (Formally known as Tenshi kaizan Private limited) Person or entity forming a part of the promoter or promoter group of the listed entity Purchase of goods or services 1,400.00 NA 600.00 04-08-2025 1,834.50 0.00 0.00
152 Biolexis PTE. Limited Arcolab Private Limited Private Companies - Promoter Group Any other transaction Support Service Charges 0.00 NA 108.20 0.00 0.00
Total value of transaction during the reporting period 96,680.90



Text Block

Textual Information(1) The existing intercorporate deposit has become part of the organization as a result of the merger approved by NCLT order.
Textual Information(2) NA
Textual Information(3) NA
Textual Information(4) NA